Fatigue, a common yet complex symptom, often presents a diagnostic challenge to healthcare professionals. The multifaceted nature of fatigue necessitates a comprehensive clinical approach for effective management.
Fatigue can be both a symptom and a disease. It is a subjective sensation of weariness, exhaustion, or lack of energy. While it can be a normal response to physical and mental exertion, persistent or excessive fatigue often indicates underlying pathology. It is essential to differentiate between normal fatigue and pathological fatigue, as the latter often signifies serious health conditions such as cancer, heart disease, and neurological disorders.
Assessing fatigue involves a thorough patient history, physical examination, and appropriate investigations. Clinicians must consider both physical and psychological factors. The history should include the duration, onset, pattern, and any associated symptoms. Physical examination can reveal signs of systemic disease. Investigations may include blood tests, imaging studies, or specialized tests depending on the suspected underlying cause.
Management of fatigue is based on treating the underlying cause, symptomatic relief, and improving the patient's quality of life. Pharmacological interventions may include medications to treat the underlying disease or symptom relief. Non-pharmacological strategies encompass lifestyle modifications, physical therapy, and psychological support. It is essential to individualize the treatment plan based on the patient's needs and preferences.
Fatigue is a complex symptom requiring a comprehensive clinical approach for effective management. Understanding the multifaceted nature of fatigue, thorough assessment, accurate diagnosis, and tailored management strategies are crucial to improving patient outcomes. As healthcare professionals, we must continue to refine our approach to fatigue, enhancing our understanding and management of this enigmatic symptom.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation